Cargando…

CD4(+)FOXP3(+) Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation

Since their discovery CD4(+)FOXP3(+) regulatory T cells (Tregs) represented a promising tool to induce tolerance in allogeneic hematopoietic cell transplantation. Preclinical models proved that adoptive transfer of Tregs or the use of compounds that can favor their function in vivo are effective for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mancusi, Antonella, Piccinelli, Sara, Velardi, Andrea, Pierini, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927932/ https://www.ncbi.nlm.nih.gov/pubmed/31921162 http://dx.doi.org/10.3389/fimmu.2019.02901

Ejemplares similares

Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation
por: Mancusi, Antonella, et al.
Publicado: (2020)

The Effect of TNF-α on Regulatory T Cell Function in Graft-versus-Host Disease
por: Mancusi, Antonella, et al.
Publicado: (2018)

The Evolution of T Cell Depleted Haploidentical Transplantation
por: Aversa, Franco, et al.
Publicado: (2019)

PB2442: BLINATUMOMAB REDIRECTS DONOR LYMPHOCYTES AGAINST CD19+ ALL WITHOUT INCREASING THE RISK OF BYSTANDER ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION
por: Mancusi, Antonella, et al.
Publicado: (2023)

Blinatumomab Redirects Donor Lymphocytes against CD19(+) Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation
por: Mancusi, Antonella, et al.
Publicado: (2023)

Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation
por: Zhang, Ping, et al.
Publicado: (2019)

Editorial: Recent Developments in Haploidentical Hematopoietic Cell Transplantation: Therapy and Complications
por: Chang, Ying-Jun, et al.
Publicado: (2021)

Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
por: Baumeister, Susanne H. C., et al.
Publicado: (2020)

HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia
por: Massei, M. S., et al.
Publicado: (2023)

Case report: HLA-haploidentical hematopoietic cell transplant with posttransplant cyclophosphamide in a patient with leukocyte adhesion deficiency type I
por: Yamashita, Motoi, et al.
Publicado: (2022)

Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia
por: Limongello, Roberto, et al.
Publicado: (2021)

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
por: Bailén, Rebeca, et al.
Publicado: (2021)

Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
por: Bailén, Rebeca, et al.
Publicado: (2023)

Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4(+) T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
por: Hadjis, Ashley D., et al.
Publicado: (2022)

NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment
por: Pierini, Antonio, et al.
Publicado: (2016)

Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation
por: Rovatti, Pier Edoardo, et al.
Publicado: (2020)

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
por: Williams, Louis, et al.
Publicado: (2020)

Commentary: Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
por: Stokes, Jessica, et al.
Publicado: (2022)

Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies
por: Zaghi, Elisa, et al.
Publicado: (2019)

Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation
por: Sanders, Jes M., et al.
Publicado: (2022)

Decreased iKIR-HLA C Pair Confers Worse Clinical Outcomes for Patients With Myeloid Disease Receiving Antithymocyte Globulin-Based Haploidentical Hematopoietic Stem Cell Transplantation
por: Zhao, Yanmin, et al.
Publicado: (2021)

Overview of the progress on haploidentical hematopoietic transplantation
por: Farhadfar, Nosha, et al.
Publicado: (2016)

Review of Haploidentical Hematopoietic Cell Transplantation
por: Khan, Mehreen A., et al.
Publicado: (2018)

A Review of Cyclophosphamide-Induced Transplantation Tolerance in Mice and Its Relationship With the HLA-Haploidentical Bone Marrow Transplantation/Post-Transplantation Cyclophosphamide Platform
por: Mayumi, Hisanori
Publicado: (2021)

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation
por: Kalin, Burak, et al.
Publicado: (2020)

Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation
por: Weber, Gerrit, et al.
Publicado: (2021)

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
por: Muñiz, Paula, et al.
Publicado: (2022)

HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma
por: Xu, Xueer, et al.
Publicado: (2023)

Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia
por: Zhang, Yuanfeng, et al.
Publicado: (2022)

Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants
por: Bottino, Cristina, et al.
Publicado: (2022)

αβT- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes
por: Merli, Pietro, et al.
Publicado: (2022)

Haploidentical Hematopoietic Stem-Cell Transplantation in Adults
por: Alshemmari, Salem, et al.
Publicado: (2011)

Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders
por: Albert, Michael H., et al.
Publicado: (2021)

Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide
por: Muñiz, Paula, et al.
Publicado: (2021)

Human and Mouse CD8(+)CD25(+)FOXP3(+) Regulatory T Cells at Steady State and during Interleukin-2 Therapy
por: Churlaud, Guillaume, et al.
Publicado: (2015)

The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia
por: Lin, Fan, et al.
Publicado: (2022)

Pre-transplant CRP–albumin ratio as a biomarker in patients receiving haploidentical allogeneic hematopoietic transplantation: Developing a novel DRCI-based nomogram
por: Wang, Kejing, et al.
Publicado: (2023)

HLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
por: Tiercy, Jean-Marie
Publicado: (2014)

T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients
por: Sodani, Pietro, et al.
Publicado: (2011)

Human CD8(+)HLA-DR(+) Regulatory T Cells, Similarly to Classical CD4(+)Foxp3(+) Cells, Suppress Immune Responses via PD-1/PD-L1 Axis
por: Machicote, Andres, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_emp40eeroa4h3hljah149mk38k